SCHEMBL12935449

SCHEMBL12935449

C1=CC2c3cc(N(c4ccccc4)c4cccc5c(N(c6ccccc6)c6ccc7c(c6)c6ccccc6n7-c6ccccc6)cccc45)ccc3N(c3ccccc3)C2C=C1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13323055 0.94 KDM4E (0.38) KDM4EATML3MBTL1
SCHEMBL11998955 0.94 KDM4E (0.38) KDM4EATML3MBTL1
SCHEMBL13448773 0.94 KDM4E (0.38) KDM4EATML3MBTL1
SCHEMBL18902994 0.93 KDM4E (0.31) KDM4EATML3MBTL1
SCHEMBL10819929 0.93 KDM4E (0.32) KDM4EATML3MBTL1
SCHEMBL13060164 0.92 KDM4E (0.36) KDM4EATML3MBTL1
SCHEMBL11926267 0.91 KDM4E (0.35) KDM4EATML3MBTL1
SCHEMBL13323120 0.91 KDM4E (0.31) KDM4EATML3MBTL1
SCHEMBL11998436 0.90 KDM4E (0.36) KDM4EATML3MBTL1
SCHEMBL8951938 0.90 KDM4E (0.36) KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2281863-A2 Fluorene-derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2011-02-09 — — EP disclosed
EP-2066150-B1 Novel red electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC (KR) 2010-05-26 — — EP disclosed
WO-2010050779-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME GRACEL DISPLAY INC. (KR) 2010-05-06 — — WO disclosed
EP-2182002-A1 Novel compounds for electronic material and organic electronic device using the same Gracel Display Inc. (KR) 2010-05-05 — — EP disclosed
EP-2182039-A2 Aromatic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-05-05 — — EP disclosed
US-20100066241-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-18 — — US disclosed
EP-2110376-A1 Novel compounds for electronic material and organic electronic device using the same Gracel Display Inc. (KR) 2009-10-21 — — EP disclosed
EP-2108690-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 — — EP disclosed
EP-2090637-A1 Organic electroluminescent compounds and light emitting diode using the same Gracel Display Inc. (KR) 2009-08-19 — — EP disclosed
EP-2080795-A1 Electroluminescent device using electroluminescent compounds Gracel Display Inc. (KR) 2009-07-22 — — EP disclosed
EP-2067766-A1 Green electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-06-10 — — EP disclosed
EP-2058322-A2 Novel red electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-05-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100066241-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same IL33, ORMDL3, CCND3 KDM4E 4343/4885ATM 4786/4885L3MBTL1 482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback